Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Healthcare Drug Manufacturers - Specialty & Generic
Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada and the state of Utah, United States. Its properties include Jubilee Mountain, Falcon and Paradox Basin. It owns a 100% interest in two barium sulphate (barite) projects, including the Frances Creek and Pedley Mountain property. It holds interests in a high-grade iodine, lithium, and bromine brine project situated in Utah, United States. It owns a 100% interest in two battery mineral projects that is focused on copper/zinc development. Its pipeline products include SmoothX 2.0%, MultiX Thick, MultiX Thin, HDX, LDX, VY-101 and VY-103.


TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(56)
•••
Post by WarrantOfficeron Dec 05, 2023 12:26pm
211 Views
Post# 35769270

From Last PR

From Last PR In response to client demand, Voyageur is currently working with Alberta Veterinarian Laboratories (AVL) and its subsidiary Solvet https://solvet.ca/, to accelerate the formulation and testing of the remaining products that the market requires to ensure supply chain security for our clients. AVL is currently formulating the next 3 products with Health Canada licences; MultiXBa, MultiXs and MultiXthin. Upon completion of our full suite of products, Voyageur will begin penetrating the Canadian radiology market.

I remain critical of present managements ability to push this project forward. They inform us on 14 Sept 2023 that they are accelerating the formulating and testing of the remaining products after 2 1/2 years since our fifth Health Canada approval. They are just getting their planning together in Sept 2023 to accelerate the testing?  

Further, it does not take much clairvoyance to predict the fact to entice new customers you must offer a complete product line to ensure customer stability in the marketplace. 

Still holding a large position in this company, but becoming more skeptical of managements ability. I would humbly tip my hat to management if they can prove me wrong. 


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities